Home LiteratureArticle Details
PMID: 8675348 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli.

Infection and immunity ·Vol. 64 ·No. 6 ·1996-06-00 ·Pages 2343-8

Russo T, Brown JJ, Jodush ST, Johnson JR

Abstract

Group 2 capsules and lipopolysaccharides are regarded as important virulence factors in extraintestinal isolates of Escherichia coli, but their specific contributions to bladder and renal infections, if any, are unknown. Proven isogenic derivatives deficient in the K54 antigen alone (CP9.137), the O4 antigen alone (CP921), or both the K54 and O4 antigens (CP923) were compared with their wild-type parent (CP9 [O4/K54JH5]) for growth in human urine in vitro and for virulence in vivo in a mouse model of ascending urinary tract infection (UTI). Growth of CP9.137 and CP921 was equivalent to that of CP9 in human urine. CP923 demonstrated a small but reproducible decrease in log-phase growth but achieved the same plateau density. In the mouse model of UTI, the isogenic mutant deficient in the 04 antigen alone (CP921) and, to a greater degree, the derivative deficient in both the K54 and O4 antigens (CP923) were significantly less virulent in nearly all parameters measured. In contrast, the K54 knockout derivative was as virulent as its parent, CP9, in causing bladder infection and nearly as virulent in causing renal infection. These results demonstrate an important role for the O4 antigen moiety of lipopolysaccharide in the pathogenesis of UTI. The possibility that the K54 antigen also plays a minor role cannot be excluded.

MeSH Terms
Animals Bacterial Capsules/physiology Escherichia coli/pathogenicity Female Humans Mice O Antigens/toxicity Urinary Tract Infections/etiology Virulence
Chemicals
O Antigens
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Russo T
Department of Medicine, State University of New York at Buffalo, USA.
Brown J J
Jodush S T
Johnson J R
References (50)
50 references, click to expand
  1. Experimental Escherichia coli urinary infection in the rat.
    Kidney Int. 1975 Oct;8(4):233-8 PMID: 1104967
  2. TnphoA-mediated disruption of K54 capsular polysaccharide genes in Escherichia coli confers serum sensitivity.
    Infect Immun. 1993 Aug;61(8):3578-82 PMID: 8392976
  3. Frequency of E. coli K antigens in urinary-tract infections in children.
    Lancet. 1977 Mar 26;1(8013):663-6 PMID: 66470
  4. Influence of O and K antigens on the surface properties of Escherichia coli in relation to phagocytosis.
    Acta Pathol Microbiol Scand B. 1979 Apr;87B(2):85-91 PMID: 375674
  5. The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.
    J Gen Microbiol. 1980 Dec;121(2):387-400 PMID: 7021764
  6. Opsonic effect of normal and infected human urine on phagocytosis of Escherichia coli and yeasts by neutrophils.
    J Urol. 1982 Feb;127(2):356-60 PMID: 7038145
  7. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
    Anal Biochem. 1982 Jan 1;119(1):115-9 PMID: 6176137
  8. Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination.
    J Hyg (Lond). 1982 Jun;88(3):567-77 PMID: 7045221
  9. Diagnosis of coliform infection in acutely dysuric women.
    N Engl J Med. 1982 Aug 19;307(8):463-8 PMID: 7099208
  10. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
    Infect Immun. 1983 Apr;40(1):273-83 PMID: 6339403
  11. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.
    J Bacteriol. 1983 Apr;154(1):269-77 PMID: 6187729
  12. K antigens of Escherichia coli and virulence in urinary-tract infection: studies in a mouse model.
    J Med Microbiol. 1983 May;16(2):147-55 PMID: 6341596
  13. The effect of urine osmolality and pH on the bactericidal activity of plasma.
    Clin Sci. 1967 Dec;33(3):471-80 PMID: 4865557
  14. Cell wall composition and virulence in Escherichia coli.
    J Exp Med. 1968 Sep 1;128(3):399-414 PMID: 4875325
  15. Antibacterial mechanisms of the urinary bladder.
    J Clin Invest. 1968 Dec;47(12):2689-700 PMID: 4881768
  16. Sensitivity of serologically classified strains of escherichia coli of human origin to the serum bactericidal system.
    Am J Med Sci. 1970 Feb;259(2):114-9 PMID: 4905231
  17. Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection.
    J Infect Dis. 1973 Jun;127(6):670-7 PMID: 4196446
  18. Urinary-tract infection: localisation and virulence of Escherichia coli.
    Lancet. 1975 Jan 18;1(7899):134-6 PMID: 46051
  19. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.
    Microbiol Rev. 1983 Mar;47(1):46-83 PMID: 6343827
  20. Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing.
    Infect Immun. 1983 Dec;42(3):907-13 PMID: 6196296
  21. The importance of the K1 capsule in invasive infections caused by Escherichia coli.
    J Infect Dis. 1984 Feb;149(2):184-93 PMID: 6199436
  22. Gal-Gal binding and hemolysin phenotypes and genotypes associated with uropathogenic Escherichia coli.
    N Engl J Med. 1985 Aug 15;313(7):414-20 PMID: 2862582
  23. Surface components of Escherichia coli that mediate resistance to the bactericidal activities of serum and phagocytes.
    Curr Top Microbiol Immunol. 1985;118:197-218 PMID: 3902381
  24. Escherichia coli in extra-intestinal infections.
    J Hyg (Lond). 1985 Dec;95(3):551-75 PMID: 2419401
  25. Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli.
    J Infect Dis. 1986 Sep;154(3):497-503 PMID: 3525697
  26. Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum.
    Infect Immun. 1987 Feb;55(2):320-8 PMID: 3804440
  27. Bacterial virulence versus host resistance in the urinary tracts of mice.
    Infect Immun. 1987 May;55(5):1224-32 PMID: 3552994
  28. Contribution of capsular polysaccharide and surface properties to virulence of Escherichia coli K1.
    Infect Immun. 1987 Nov;55(11):2662-8 PMID: 3312006
  29. Polysaccharide antigens of Escherichia coli.
    Rev Infect Dis. 1987 Sep-Oct;9 Suppl 5:S517-26 PMID: 2446369
  30. Polyacrylamide gel electrophoresis of the capsular polysaccharides of Escherichia coli K1 and other bacteria.
    J Bacteriol. 1988 Jun;170(6):2646-53 PMID: 3286615
  31. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection.
    J Clin Microbiol. 1988 Aug;26(8):1471-6 PMID: 3049654
  32. Complement evasion by bacteria and parasites.
    Annu Rev Microbiol. 1988;42:201-30 PMID: 3059994
  33. Virulence of wild-type E. coli uroisolates in experimental pyelonephritis.
    Kidney Int. 1988 Dec;34(6):761-5 PMID: 2905397
  34. The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli.
    Infect Immun. 1990 Jan;58(1):222-7 PMID: 2403532
  35. The biologic significance of bacterial encapsulation.
    Curr Top Microbiol Immunol. 1990;150:87-95 PMID: 2404691
  36. Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days.
    J Infect Dis. 1991 Feb;163(2):325-30 PMID: 1988516
  37. Generation of isogenic K54 capsule-deficient Escherichia coli strains through TnphoA-mediated gene disruption.
    Mol Microbiol. 1993 Jul;9(2):357-64 PMID: 8412686
  38. The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo.
    J Infect Dis. 1994 Jan;169(1):112-8 PMID: 8277173
  39. Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria.
    J Infect Dis. 1994 Jan;169(1):95-104 PMID: 8277203
  40. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis.
    Ann Intern Med. 1994 May 1;120(9):771-83 PMID: 8147551
  41. Loss of the O4 antigen moiety from the lipopolysaccharide of an extraintestinal isolate of Escherichia coli has only minor effects on serum sensitivity and virulence in vivo.
    Infect Immun. 1995 Apr;63(4):1263-9 PMID: 7890383
  42. Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid immediate vesicoureteral reflux yet produce renal and bladder infection.
    J Infect Dis. 1996 Mar;173(3):746-9 PMID: 8627045
  43. Depression of phagocytosis by solutes in concentrations found in the kidney and urine.
    J Clin Invest. 1962 Oct;41:1945-53 PMID: 14020591
  44. The anticomplementary effect of kidney tissue; its association with ammonia production.
    J Exp Med. 1959 Nov 1;110:685-97 PMID: 13798253
  45. Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: efficacy of an alpha-hemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis.
    Infect Immun. 1991 Mar;59(3):1153-61 PMID: 1671776
  46. Virulence factors in Escherichia coli urinary tract infection.
    Clin Microbiol Rev. 1991 Jan;4(1):80-128 PMID: 1672263
  47. Histopathologic-microbiologic correlates of invasiveness in a mouse model of ascending unobstructed urinary tract infection.
    J Infect Dis. 1992 Feb;165(2):299-305 PMID: 1730896
  48. Detailed histopathological examination contributes to the assessment of Escherichia coli urovirulence.
    J Urol. 1992 Apr;147(4):1160-6 PMID: 1552614
  49. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat.
    J Clin Invest. 1992 Sep;90(3):897-905 PMID: 1326000
  50. Agarose electrophoresis combined with second dimensional Cetavlon precipitation. A new method for demonstration of acidic polysaccharide K antigens.
    Acta Pathol Microbiol Scand B. 1976 Oct;84B(5):319-20 PMID: 61707
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1996-06-00
Pages
2343-8
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC174077
Subset
IM
Grants
NIDDK NIH HHS · R01 DK47504 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com